Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
ESMO Open|March 16, 2024
Elements of successful patient involvement in clinical cancer trials: a review of the literatureI Shakhnenko, O Husson, D Chuter, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2008
EORTC-GCG process quality indicators for ovarian cancer surgeryL Verleye, P B Ottevanger, W van der Graaf, et al.
Journal of Personalized Medicine|July 27, 2022
Reproducibility of 2D and 3D Ramus Height Measurements in Facial AsymmetryNicolaas B van Bakelen, Jasper W van der Graaf, Joep Kraeima, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 9, 2023
MRI image features with an evident relation to low back pain: a narrative reviewJasper W van der Graaf, Robert Jan Kroeze, Constantinus F M Buckens, et al.
European Radiology|February 22, 2024
Development and validation of AI-based automatic measurement of coronal Cobb angles in degenerative scoliosis using sagittal lumbar MRIJasper W van der Graaf, Miranda L van Hooff, Bram van Ginneken, et al.
Scientific Data|March 2, 2024
Lumbar spine segmentation in MR images: a dataset and a public benchmarkJasper W van der Graaf, Miranda L van Hooff, Constantinus F M Buckens, et al.
European Radiology|September 19, 2024
AI-based lumbar central canal stenosis classification on sagittal MR images is comparable to experienced radiologists using axial imagesJasper W van der Graaf, Liron Brundel, Miranda L van Hooff, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2003
Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II studyJ Verweij, A van Oosterom, J-Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor GroupR Stupp, A Tosoni, J E C Bromberg, et al.
ESMO Open|June 19, 2022
Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma NetworkA Smrke, A M Frezza, C Giani, et al.
Pageof 2